Naproxen for Pain Control With Intrauterine Device Insertion
Status:
Completed
Trial end date:
2016-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is:
1. To evaluate whether 550 mg of naproxen sodium reduces pain scores with IUD insertion on
a 0-10cm visual analogue scale compared to placebo (primary outcome).
2. To evaluate whether 550 mg of naproxen sodium reduces pain scores with tenaculum
placement, uterine sounding and post-procedurally on a 0-10 cm visual analog scale
compared to placebo (secondary outcomes).
3. To establish if prophylactic naproxen sodium is acceptable for routine use prior to IUD
insertion.
Hypothesis: The administration of naproxen sodium, 550mg orally, 1 hour prior to IUD
insertion will lead to a reduction in pain scores associated with IUD insertion compared to
placebo.